28 April 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics reviews the efficacy of anti-tumor necrosis factor-alpha agents for the treatment of ulcerative colitis.
Antibodies against tumor necrosis factor-alpha (anti-TNF) are effective therapies in the treatmen
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors